Patients with chronic liver disease & intractable pruritus
Nalfurafine capsules 2.5 μg, oral dispersing tablets 2.5 μg) in 1,186 patients with chronic liver disease and intractable pruritus.
Nalfurafine Remitch Toray Industries Inc Japanese Ministry Of Health Administration Child Japanese Pharmaceutical Affairs Law Research Laboratories Of Toray Industries Inc
Source: dovepress.com